标题
Prognostic biomarkers in endometrial and ovarian carcinoma
作者
关键词
Endometrial carcinoma, Ovarian carcinoma, Biomarkers, Prognosis
出版物
VIRCHOWS ARCHIV
Volume 464, Issue 3, Pages 315-331
出版商
Springer Nature
发表日期
2014-02-06
DOI
10.1007/s00428-013-1509-y
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Expression of Class I Histone Deacetylases Indicates Poor Prognosis in Endometrioid Subtypes of Ovarian and Endometrial Carcinomas
- (2015) Wilko Weichert et al. NEOPLASIA
- LAPTM4Bgene polymorphism and endometrial carcinoma risk and prognosis
- (2013) Fanling Meng et al. BIOMARKERS
- Low expression of the X-linked ribosomal protein S4 in human serous epithelial ovarian cancer is associated with a poor prognosis
- (2013) Serges P Tsofack et al. BMC CANCER
- Expression of steroid receptor coactivator 3 in ovarian epithelial cancer is a poor prognostic factor and a marker for platinum resistance
- (2013) C Palmieri et al. BRITISH JOURNAL OF CANCER
- Analysis of Over 10,000 Cases Finds No Association between Previously Reported Candidate Polymorphisms and Ovarian Cancer Outcome
- (2013) K. L. White et al. CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION
- Identification of FGFR4 as a Potential Therapeutic Target for Advanced-Stage, High-Grade Serous Ovarian Cancer
- (2013) T. M. Zaid et al. CLINICAL CANCER RESEARCH
- High Phospho-Stathmin(Serine38) Expression Identifies Aggressive Endometrial Cancer and Suggests an Association with PI3K Inhibition
- (2013) E. Wik et al. CLINICAL CANCER RESEARCH
- New Strategies in the Treatment of Ovarian Cancer: Current Clinical Perspectives and Future Potential
- (2013) S. Banerjee et al. CLINICAL CANCER RESEARCH
- Trefoil factor family 3 (TFF3) expression and its interaction with estrogen receptor (ER) in endometrial adenocarcinoma
- (2013) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival
- (2013) Helene Tuft Stavnes et al. GYNECOLOGIC ONCOLOGY
- Visfatin, a potential biomarker and prognostic factor for endometrial cancer
- (2013) Wenyan Tian et al. GYNECOLOGIC ONCOLOGY
- Prognostic role of cyclooxygenase-2 in epithelial ovarian cancer: A meta-analysis of observational studies
- (2013) Jung-Yun Lee et al. GYNECOLOGIC ONCOLOGY
- Poly(adenosine diphosphate-ribose) polymerase expression in BRCA-proficient ovarian high-grade serous carcinoma; association with patient survival
- (2013) Alex Gan et al. HUMAN PATHOLOGY
- Aldehyde dehydrogenase 1/epidermal growth factor receptor coexpression is characteristic of a highly aggressive, poor-prognosis subgroup of high-grade serous ovarian carcinoma
- (2013) Catarina Alisa Liebscher et al. HUMAN PATHOLOGY
- Overexpression of Wnt7a Is Associated With Tumor Progression and Unfavorable Prognosis in Endometrial Cancer
- (2013) Yunduo Liu et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Hormone-receptor expression and ovarian cancer survival: an Ovarian Tumor Tissue Analysis consortium study
- (2013) Weiva Sieh et al. LANCET ONCOLOGY
- Combination of Vorinostat and caspase-8 inhibition exhibits high anti-tumoral activity on endometrial cancer cells
- (2013) Laura Bergadà et al. Molecular Oncology
- Integrated genomic characterization of endometrial carcinoma
- (2013) Gad Getz et al. NATURE
- Stem Cell-Like Gene Expression in Ovarian Cancer Predicts Type II Subtype and Prognosis
- (2013) Matthew Schwede et al. PLoS One
- Integrated Genomic Analysis of the 8q24 Amplification in Endometrial Cancers Identifies ATAD2 as Essential to MYC-Dependent Cancers
- (2013) Maria B. Raeder et al. PLoS One
- Value of PAX 8 Immunostaining in Tumor Diagnosis
- (2012) Nelson G. Ordóñez ADVANCES IN ANATOMIC PATHOLOGY
- Prognostic significance of L1CAM in ovarian cancer and its role in constitutive NF-κB activation
- (2012) S. Bondong et al. ANNALS OF ONCOLOGY
- Lipocalin 2 expression is associated with aggressive features of endometrial cancer
- (2012) Monica Mannelqvist et al. BMC CANCER
- Loss of GPER identifies new targets for therapy among a subgroup of ERα-positive endometrial cancer patients with poor outcome
- (2012) C Krakstad et al. BRITISH JOURNAL OF CANCER
- Associations between hepatocyte growth factor, c-Met and basic fibroblast growth factor and survival in endometrial cancer patients
- (2012) A S Felix et al. BRITISH JOURNAL OF CANCER
- KRAS gene amplification and overexpression but not mutation associates with aggressive and metastatic endometrial cancer
- (2012) E Birkeland et al. BRITISH JOURNAL OF CANCER
- Cancer statistics, 2012
- (2012) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Biologic rationale and clinical activity of mTOR inhibitors in gynecological cancer
- (2012) Ivan Diaz-Padilla et al. CANCER TREATMENT REVIEWS
- Pre-treatment tumor expression of ERCC1 in women with advanced stage epithelial ovarian cancer is not predictive of clinical outcomes: A gynecologic oncology group study
- (2012) Jennifer M. Rubatt et al. GYNECOLOGIC ONCOLOGY
- Pair Box 8 (PAX8) protein expression in high grade, late stage (stages III and IV) ovarian serous carcinoma
- (2012) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Somatic hypermutation and outcomes of platinum based chemotherapy in patients with high grade serous ovarian cancer
- (2012) Insuk Sohn et al. GYNECOLOGIC ONCOLOGY
- Prognostic role of indoleamine 2,3-dioxygenase in endometrial carcinoma
- (2012) Renske A. de Jong et al. GYNECOLOGIC ONCOLOGY
- Validation of ovarian cancer gene expression signatures for survival and subtype in formalin fixed paraffin embedded tissues
- (2012) Gregory P. Sfakianos et al. GYNECOLOGIC ONCOLOGY
- Migfilin, α-parvin and β-parvin are differentially expressed in ovarian serous carcinoma effusions, primary tumors and solid metastases
- (2012) Ben Davidson et al. GYNECOLOGIC ONCOLOGY
- The prognostic value of vascular endothelial growth factor in ovarian cancer: A systematic review and meta-analysis
- (2012) Lei Yu et al. GYNECOLOGIC ONCOLOGY
- High-throughput interrogation of PIK3CA, PTEN, KRAS, FBXW7 and TP53 mutations in primary endometrial carcinoma
- (2012) Diego A. Garcia-Dios et al. GYNECOLOGIC ONCOLOGY
- Immunohistochemical features of post-radiation vaginal recurrences of endometrioid carcinomas of the endometrium: role for proteins involved in resistance to apoptosis and hypoxia
- (2012) Maria Santacana et al. HISTOPATHOLOGY
- Elevated expression of astrocyte elevated gene-1 (AEG-1) is correlated with cisplatin-based chemoresistance and shortened outcome in patients with stages III-IV serous ovarian carcinoma
- (2012) Cong Li et al. HISTOPATHOLOGY
- Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum)
- (2012) Deborah DeLair et al. HISTOPATHOLOGY
- PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma
- (2012) Azusa Abe et al. HUMAN PATHOLOGY
- Loss of HLA class I and mismatch repair protein expression in sporadic endometrioid endometrial carcinomas
- (2012) Renske A. de Jong et al. INTERNATIONAL JOURNAL OF CANCER
- Clear Cell Carcinomas of the Ovary
- (2012) Kyueng-Whan Min et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL PATHOLOGY
- The autophagy protein LC3A correlates with hypoxia and is a prognostic marker of patient survival in clear cell ovarian cancer
- (2012) Jaeline E Spowart et al. JOURNAL OF PATHOLOGY
- A DNA Repair Pathway–Focused Score for Prediction of Outcomes in Ovarian Cancer Treated With Platinum-Based Chemotherapy
- (2012) Josephine Kang et al. JNCI-Journal of the National Cancer Institute
- Contemporary management of endometrial cancer
- (2012) Jason D Wright et al. LANCET
- Markers for individualised therapy in endometrial carcinoma
- (2012) Helga B Salvesen et al. LANCET ONCOLOGY
- Role of TRAP1 and estrogen receptor alpha in patients with ovarian cancer -A study of the OVCAD consortium
- (2012) Stefanie Aust et al. Molecular Cancer
- Blockade of NFκB activity by Sunitinib increases cell death in Bortezomib-treated endometrial carcinoma cells
- (2012) Anabel Sorolla et al. Molecular Oncology
- Endometrial carcinoma: molecular alterations involved in tumor development and progression
- (2012) A Yeramian et al. ONCOGENE
- Differing clinical impact ofBRCA1andBRCA2mutations in serous ovarian cancer
- (2012) Guoyan Liu et al. PHARMACOGENOMICS
- FGFR2 Point Mutations in 466 Endometrioid Endometrial Tumors: Relationship with MSI, KRAS, PIK3CA, CTNNB1 Mutations and Clinicopathological Features
- (2012) Sara A. Byron et al. PLoS One
- Prognostic Significance of miR-205 in Endometrial Cancer
- (2012) Mihriban Karaayvaz et al. PLoS One
- Genotype-Dependent Efficacy of a Dual PI3K/mTOR Inhibitor, NVP-BEZ235, and an mTOR Inhibitor, RAD001, in Endometrial Carcinomas
- (2012) Keiko Shoji et al. PLoS One
- Anterior gradient protein 2 (AGR2) is an independent prognostic factor in ovarian high-grade serous carcinoma
- (2012) S. Darb-Esfahani et al. VIRCHOWS ARCHIV
- Rab25 is overexpressed in Müllerian serous carcinoma compared to malignant mesothelioma
- (2012) Kjersti Brusegard et al. VIRCHOWS ARCHIV
- Ovarian carcinomas: five distinct diseases with different origins, genetic alterations, and clinicopathological features
- (2012) Jaime Prat VIRCHOWS ARCHIV
- Prognostic significance of residual tumor in patients with epithelial ovarian carcinoma stage IV in a 20 year perspective
- (2011) MARI B. ELSTRAND et al. ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA
- WT1 Expression in the Female Genital Tract
- (2011) Carmen Bárcena et al. ADVANCES IN ANATOMIC PATHOLOGY
- Gene Expression Patterns Related to Vascular Invasion and Aggressive Features in Endometrial Cancer
- (2011) Monica Mannelqvist et al. AMERICAN JOURNAL OF PATHOLOGY
- Breast cancer 1 (BRCA1) protein expression as a prognostic marker in sporadic epithelial ovarian carcinoma: an NCIC CTG OV.16 correlative study
- (2011) J. I. Weberpals et al. ANNALS OF ONCOLOGY
- Prognostic importance of DNA ploidy and DNA index in stage I and II endometrioid adenocarcinoma of the endometrium
- (2011) M. Pradhan et al. ANNALS OF ONCOLOGY
- A seven-gene prognostic model for platinum-treated ovarian carcinomas
- (2011) R Sabatier et al. BRITISH JOURNAL OF CANCER
- Prognostic and therapeutic impact of the chromosome 20q13.2 ZNF217 locus amplification in ovarian clear cell carcinoma
- (2011) Mohammed Tanjimur Rahman et al. CANCER
- Genomic Analysis Reveals the Molecular Heterogeneity of Ovarian Clear Cell Carcinomas
- (2011) David S.P. Tan et al. CLINICAL CANCER RESEARCH
- BRCA1 is both a prognostic and predictive biomarker of response to chemotherapy in sporadic epithelial ovarian cancer
- (2011) Judith E. Carser et al. GYNECOLOGIC ONCOLOGY
- Synuclein-γ (SNCG) protein expression is associated with poor outcome in endometrial adenocarcinoma
- (2011) Paulette Mhawech-Fauceglia et al. GYNECOLOGIC ONCOLOGY
- Prognostic significance of tumor-infiltrating T cells in ovarian cancer: A meta-analysis
- (2011) Wei-Ting Hwang et al. GYNECOLOGIC ONCOLOGY
- Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance
- (2011) Thea Eline Hetland et al. HUMAN PATHOLOGY
- Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer—Shifting the paradigm
- (2011) Robert J. Kurman et al. HUMAN PATHOLOGY
- Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions
- (2011) Mari Bunkholt Elstrand et al. HUMAN PATHOLOGY
- Fibroblast growth factor receptor 4 gene (FGFR4) 388Arg allele predicts prolonged survival and platinum sensitivity in advanced ovarian cancer
- (2011) Frederik Marmé et al. INTERNATIONAL JOURNAL OF CANCER
- Pathology of primary and metastatic mucinous ovarian neoplasms
- (2011) Sarah Lam Shang Leen et al. JOURNAL OF CLINICAL PATHOLOGY
- Immunohistochemistry in the distinction between primary and metastatic ovarian mucinous neoplasms: Table 1
- (2011) W Glenn McCluggage JOURNAL OF CLINICAL PATHOLOGY
- TP53 mutations in serous tubal intraepithelial carcinoma and concurrent pelvic high-grade serous carcinoma-evidence supporting the clonal relationship of the two lesions
- (2011) Elisabetta Kuhn et al. JOURNAL OF PATHOLOGY
- AURKA and BRCA2 expression highly correlate with prognosis of endometrioid ovarian carcinoma
- (2011) Fan Yang et al. MODERN PATHOLOGY
- Biomarkers and microsatellite instability analysis of curettings can predict the behavior of FIGO stage I endometrial endometrioid adenocarcinoma
- (2011) Anita Steinbakk et al. MODERN PATHOLOGY
- Gene amplification and protein overexpression of MET are common events in ovarian clear-cell adenocarcinoma: their roles in tumor progression and prognostication of the patient
- (2011) Sohei Yamamoto et al. MODERN PATHOLOGY
- Integrated genomic analyses of ovarian carcinoma
- (2011) D. Bell et al. NATURE
- Integrated Analysis of Multiple Microarray Datasets Identifies a Reproducible Survival Predictor in Ovarian Cancer
- (2011) Panagiotis A. Konstantinopoulos et al. PLoS One
- Microarray-Based Oncogenic Pathway Profiling in Advanced Serous Papillary Ovarian Carcinoma
- (2011) Xuan Bich Trinh et al. PLoS One
- Endoglin (CD105) expression in ovarian serous carcinoma effusions is related to chemotherapy status
- (2011) Annika J. Bock et al. TUMOR BIOLOGY
- PIK3CA mutations and loss of ARID1A protein expression are early events in the development of cystic ovarian clear cell adenocarcinoma
- (2011) Sohei Yamamoto et al. VIRCHOWS ARCHIV
- The multikinase inhibitor Sorafenib induces apoptosis and sensitises endometrial cancer cells to TRAIL by different mechanisms
- (2010) D. Llobet et al. EUROPEAN JOURNAL OF CANCER
- Identification of a Gene Expression Signature for Survival Prediction in Type I Endometrial Carcinoma
- (2010) KRISTINA LEVAN et al. GENE EXPRESSION
- MicroRNA signatures differentiate uterine cancer tumor subtypes
- (2010) Elena S. Ratner et al. GYNECOLOGIC ONCOLOGY
- “Primary peritoneal” high-grade serous carcinoma is very likely metastatic from serous tubal intraepithelial carcinoma: Assessing the new paradigm of ovarian and pelvic serous carcinogenesis and its implications for screening for ovarian cancer
- (2010) Jeffrey D. Seidman et al. GYNECOLOGIC ONCOLOGY
- Aromatase, Cyclooxygenase 2, HER-2/neu, and P53 as Prognostic Factors in Endometrioid Endometrial Cancer
- (2010) Vincent H.W.M. Jongen et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Gene Expression Profiling of Endometrial Adenocarcinomas Reveals Increased Apolipoprotein E Expression in Poorly Differentiated Tumors
- (2010) Jutta Huvila et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Molecular classification of human endometrial cancer based on gene expression profiles from specialized microarrays
- (2010) YuanYang Yao et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Endometrial carcinoma: controversies in histopathological assessment of grade and tumour cell type
- (2010) B. A. Clarke et al. JOURNAL OF CLINICAL PATHOLOGY
- Driver mutations in TP53 are ubiquitous in high grade serous carcinoma of the ovary
- (2010) Ahmed Ashour Ahmed et al. JOURNAL OF PATHOLOGY
- PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors
- (2010) K. J. Dedes et al. Science Translational Medicine
- Resistance to chemotherapy and hormone therapy in endometrial cancer
- (2009) Parvesh Chaudhry et al. ENDOCRINE-RELATED CANCER
- Down-regulation of proteasomal subunit MB1 is an independent predictor of improved survival in ovarian cancer
- (2009) Ninke Leffers et al. GYNECOLOGIC ONCOLOGY
- Cleaved caspase-3 and nuclear factor-κB p65 are prognostic factors in metastatic serous ovarian carcinoma
- (2009) Lilach Kleinberg et al. HUMAN PATHOLOGY
- Ovarian cancer
- (2009) Bryan T Hennessy et al. LANCET
- IGF2BP3 (IMP3) expression is a marker of unfavorable prognosis in ovarian carcinoma of clear cell subtype
- (2009) Martin Köbel et al. MODERN PATHOLOGY
- Systematic Analysis of Immune Infiltrates in High-Grade Serous Ovarian Cancer Reveals CD20, FoxP3 and TIA-1 as Positive Prognostic Factors
- (2009) Katy Milne et al. PLoS One
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activation
- (2009) H. B. Salvesen et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- The ErbB signalling pathway: protein expression and prognostic value in epithelial ovarian cancer
- (2008) P de Graeff et al. BRITISH JOURNAL OF CANCER
- The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro
- (2008) P M O'Brien et al. BRITISH JOURNAL OF CANCER
- Prognostic significance of tumor-infiltrating T-lymphocytes in primary and metastatic lesions of advanced stage ovarian cancer
- (2008) Ninke Leffers et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Novel Molecular Subtypes of Serous and Endometrioid Ovarian Cancer Linked to Clinical Outcome
- (2008) R. W. Tothill et al. CLINICAL CANCER RESEARCH
- Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian Cancer
- (2008) M. J. Callahan et al. CLINICAL CANCER RESEARCH
- Adjuvant Chemotherapy in Endometrial Carcinoma: Overview of Randomised Trials
- (2008) T. Hogberg CLINICAL ONCOLOGY
- Amplification of 11q13 in ovarian carcinoma
- (2008) Lindsay A. Brown et al. GENES CHROMOSOMES & CANCER
- The prognostic significance of elongation factor eEF1A2 in ovarian cancer
- (2008) Dixie E. Pinke et al. GYNECOLOGIC ONCOLOGY
- Expression of estrogen receptor-alpha and -beta and progesterone receptor-A and -B in a large cohort of patients with endometrioid endometrial cancer
- (2008) Vincent Jongen et al. GYNECOLOGIC ONCOLOGY
- Tumor cell type can be reproducibly diagnosed and is of independent prognostic significance in patients with maximally debulked ovarian carcinoma
- (2008) C. Blake Gilks et al. HUMAN PATHOLOGY
- Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints
- (2008) D Llobet et al. JOURNAL OF CLINICAL PATHOLOGY
- Intraepithelial T cells and prognosis in ovarian carcinoma: novel associations with stage, tumor type and BRCA1 loss
- (2008) Blaise Clarke et al. MODERN PATHOLOGY
- Drug-sensitive FGFR2 mutations in endometrial carcinoma
- (2008) A. Dutt et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeted therapies in gynecologic cancers and melanoma
- (2008) Eugenia Ortega et al. SEMINARS IN DIAGNOSTIC PATHOLOGY
- Ovarian Carcinoma Subtypes Are Different Diseases: Implications for Biomarker Studies
- (2008) Martin Köbel et al. PLOS MEDICINE
- Reproducibility of grading systems for endometrial endometrioid carcinoma and their relation with pathologic prognostic parameters
- (2007) N. KAPUCUOGLU et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now